Literature DB >> 12941023

The discovery of the antiplatelet effect of aspirin: a personal reminiscence.

H J Weiss1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941023     DOI: 10.1046/j.1538-7836.2003.00433.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

Review 1.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

Review 2.  Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions.

Authors:  Anetta Undas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

Review 3.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 4.  Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions.

Authors:  Sabrina N Copsel; Thomas R Malek; Robert B Levy
Journal:  Am J Pathol       Date:  2020-08-01       Impact factor: 4.307

Review 5.  The discovery of aspirin's antithrombotic effects.

Authors:  Jonathan Miner; Adam Hoffhines
Journal:  Tex Heart Inst J       Date:  2007

6.  The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia.

Authors:  Sara Alberti; Qianqian Zhang; Ilaria D'Agostino; Annalisa Bruno; Stefania Tacconelli; Annalisa Contursi; Simone Guarnieri; Melania Dovizio; Lorenza Falcone; Patrizia Ballerini; Götz Münch; Ying Yu; Paola Patrignani
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.